Altmetric

Terminology for cone dimensions after local conservative treatment for cervical intraepithelial neoplasia and early invasive cervical cancer: 2022 consensus recommendations from ESGO, EFC, IFCPC, and ESP

File Description SizeFormat 
ManuscriptRevisedCleanCopy.docxAccepted version183.2 kBMicrosoft WordView/Open
Title: Terminology for cone dimensions after local conservative treatment for cervical intraepithelial neoplasia and early invasive cervical cancer: 2022 consensus recommendations from ESGO, EFC, IFCPC, and ESP
Authors: Kyrgiou, M
Athanasiou, A
Arbyn, M
Lax, SF
Raspollini, MR
Nieminen, P
Carcopino, X
Bornstein, J
Gultekin, M
Paraskevaidis, E
Item Type: Journal Article
Abstract: Local cervical treatment for squamous intraepithelial lesion (SIL) or cervical intraepithelial neoplasia (CIN) removes or ablates a cone-shaped or dome-shaped part of the cervix that contains abnormal cells. This Series paper introduces the 2022 terminology for cone dimensions after local conservative treatment for SIL, CIN, or early invasive cervical cancer. The terminology was prepared by the Nomenclature Committee of the European Society of Gynaecologic Oncology, the European Federation for Colposcopy, the International Federation of Cervical Pathology and Colposcopy, and the European Society of Pathology. Cone length should be tailored to the type of transformation zone. Treatment of SIL or CIN is associated with an increased risk of preterm birth, which escalates with increasing cone length. There is a lack of agreement regarding terms used to report excised specimen dimensions both intraoperatively and in the pathology laboratory. Consensus is needed to make studies addressing effectiveness and safety of SIL or CIN treatment comparable, and to facilitate their use to improve accuracy of antenatal surveillance and management. This Series paper summarises the current terminology through a review of existing literature, describes new terminology as agreed by a group of experts from international societies in the field of cervical cancer prevention and treatment, and recommends use of the new terminology that will facilitate communication between clinicians and foster more specific treatment guidelines that balance obstetrical harm against therapeutic effectiveness.
Issue Date: Aug-2022
Date of Acceptance: 1-Jul-2022
URI: http://hdl.handle.net/10044/1/98918
DOI: 10.1016/s1470-2045(22)00191-7
ISSN: 1470-2045
Publisher: Elsevier BV
Start Page: e385
End Page: e392
Journal / Book Title: The Lancet Oncology
Volume: 23
Issue: 8
Copyright Statement: © 2022 Elsevier Ltd. All rights reserved. This manuscript is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Licence http://creativecommons.org/licenses/by-nc-nd/4.0/
Sponsor/Funder: European Society of Gynaecological Oncology (ESGO)
Funder's Grant Number: WSCR_P78368
Keywords: Cervical Intraepithelial Neoplasia
Colposcopy
Consensus
Conservative Treatment
Female
Humans
Infant, Newborn
Pregnancy
Premature Birth
Uterine Cervical Neoplasms
Humans
Cervical Intraepithelial Neoplasia
Premature Birth
Colposcopy
Consensus
Pregnancy
Infant, Newborn
Uterine Cervical Neoplasms
Female
Conservative Treatment
Oncology & Carcinogenesis
1112 Oncology and Carcinogenesis
Publication Status: Published
Online Publication Date: 2022-07-25
Appears in Collections:Department of Metabolism, Digestion and Reproduction



This item is licensed under a Creative Commons License Creative Commons